Single-Use Bioprocessing Market to Reach US$25.40B by 2031, Driven by Biologics Demand & Flexible Production | Applikon Biotechnology, Cesco Bioengineering Co, Danaher Corporation, PBS Biotech Inc and Thermo Fisher Scientific

The Single-use Bioprocessing market was valued at US$ 7.62 billion in 2021 and is projected to grow significantly, reaching approximately US$ 25.40 billion by 2031. This growth represents a strong compound annual growth rate (CAGR) of 18.93% during the forecast period from 2024 to 2031.

The Single-Use Bioprocessing Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/single-use-bioprocessing-market?sg

Market Drivers:
Several key factors are fueling the growth of the single-use bioprocessing market:

Rising Demand for Biologics:
The global surge in demand for monoclonal antibodies, vaccines, and cell & gene therapies is pushing manufacturers to adopt flexible, scalable, and contamination-free bioprocessing solutions.

Reduced Risk of Cross-Contamination:
Single-use systems minimize the risk of product contamination, particularly in multiproduct facilities. This advantage is especially critical for personalized medicines and small-batch production.

Operational Efficiency and Cost Savings:
By eliminating the need for cleaning and sterilization between production cycles, single-use technologies reduce downtime, water usage, and labor costs-leading to faster turnaround and increased productivity.

Flexibility and Scalability:
The modular nature of single-use systems supports quick changeovers and scalability from clinical to commercial production, enabling biopharma companies to respond rapidly to market demand shifts.

Growth of Contract Manufacturing and Research:
The rise of contract development and manufacturing organizations (CDMOs and CROs) is contributing to wider adoption of single-use bioprocessing as they seek flexible solutions to meet diverse client needs.

Technological Advancements:
Innovations in bioreactor design, sensor integration, and automation are enhancing the performance and reliability of single-use systems, driving their appeal across the biopharma value chain.

Market Geographical Share:
The global single-use bioprocessing market shows strong regional variations in growth and adoption:

North America holds a significant share of the market, primarily driven by the presence of advanced biopharmaceutical manufacturing infrastructure, early adoption of innovative technologies, and supportive regulatory frameworks. The United States, in particular, is a frontrunner due to high R&D investments and a strong pipeline of biologics.

Europe follows closely, with countries such as Germany, the UK, and Switzerland leading the way. The region benefits from a well-established pharmaceutical sector and increasing reliance on modular and flexible production technologies to streamline biologics manufacturing.

Asia-Pacific is emerging as the fastest-growing region. China, India, and South Korea are key contributors, fueled by rising government support for biomanufacturing, growing clinical trial activity, and increased demand for cost-effective production solutions. Local players are increasingly adopting single-use systems to scale up manufacturing capabilities while maintaining quality.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/single-use-bioprocessing-market?sg

Strategic Players Driving the Single-Use Bioprocessing Market: 3M Company, Applikon Biotechnology, Cesco Bioengineering Co., Danaher Corporation, General Electric Company, Merck KGaA, PBS Biotech Inc., and Thermo Fisher Scientific Inc.

Mergers & Acquisitions (2025):
Thermo Fisher Scientific announced a planned acquisition of Solventum's purification and filtration business for approximately $4.1 billion, expected to close by the end of 2025. This positions Thermo Fisher to expand into filtration devices within bioprocessing-a segment it previously lacked-and complements its existing bioprocessing portfolio.

Strategic Partnerships & Collaborations:

Danaher (via Cytiva) entered a co‐development alliance with Cytiva to innovate advanced single‐use technologies, reinforcing its purification and processing solutions.

GE Healthcare (now part of Danaher's portfolio) teamed up with NIBRT (National Institute for Bioprocessing Research & Training) to advance training and adoption of single‐use bioprocessing technologies in cell‐therapy manufacturing.

Thermo Fisher extended its collaboration with Arsenal Biosciences to optimize programmable T‐cell manufacturing, building on synergies between single‐use platform capabilities and cutting‐edge cell therapy production workflows.

Research Methodology:

The global Single-Use Bioprocessing Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Single-Use Bioprocessing Market:

By Product (Media Bags and Containers, Filtration Assemblies, Disposable/Single-Use Bioreactors, Disposable Mixers, Others)

By Application (Filtration, Storage, Cell Culture, Mixing, Purification)

By End-Users (Biopharmaceutical Manufacturers, Life Science R&D Companies, Academic Research Institutes, Contract Research Organizations & Manufacturers, Others)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Regional Analysis for Single-Use Bioprocessing Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Single-Use Bioprocessing Market Research Industry:

➠ Who leads the Single-Use Bioprocessing industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Single-Use Bioprocessing market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Single-Use Bioprocessing market growth?

➠ What are the dominant sales and distribution strategies in the Single-Use Bioprocessing industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.